micronized flavonoid fraction

PreclinicalSmall molecule

micronized flavonoid fraction is one of 7 small molecule programs targeting Preoperative. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PreoperativeCompleted

PreoperativePreclinical

Completed

Competition

Competitive Landscape

10 competitors in Preoperative

#DrugCompanyPhaseTrials

Neurontin

VViatris Specialty LLC

Approved

3 2

Gleevec

Novartis

Phase 3

2 3

Flagyl

DDePuy Orthopaedics

Phase 2

2 4

Inderal

WWyeth-Lederle Vaccines

Phase 2

1 5

Anlotinib Hydrochloride

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 2

1 6

Zanaflex

LLegacy Health System

Preclinical

1 7

micronized flavonoid fraction

CCenter of Endourology "Endocenter"

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Preoperative1 trial

Preoperative Micronized Flavonoid Fraction (MFF) Use in Multimodal Anesthesia in Anorectal Surgery

Completed·CCenter of Endourology "Endocenter"·N/A·NCT05772351·182 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for micronized flavonoid fraction. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — micronized flavonoid fraction compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for micronized flavonoid fraction. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Center of Endourology "Endocenter" company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CCenter of Endourology "Endocenter"

micronized flavonoid fraction

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Preoperative1 trial

References

Drug Info

Quick Facts

Related News